MedPath

Late Night Snack and Insulin Glargine

Not Applicable
Completed
Conditions
Type 1 Diabetes
Hypoglycemia
Interventions
Other: No late night snack
Dietary Supplement: Late night snack
Registration Number
NCT02871180
Lead Sponsor
Diabeteszentrum Bad Lauterberg im Harz
Brief Summary

Twenty patient with Type 1 diabetes, using insulin glargine as basal insulin, participated in a prospective, controlled crossover trial comparing blood glucose profiles over two 24 h periods with and without a late night snack (a slice of rye bread, 20 g carbohydrates, at 10 p.m.), in randomized order. The main endpoint was the number of hypoglycemic episodes with a confirmed laboratory blood glucose ≤ 50 mg/dl between 10 p.m. and 8 p.m. the following day. Secondary endpoint was the blood glucose profile during this period.

Detailed Description

The order of studies (with and without a late night snack) was determined by randomization. Study-related procedures started at 6 p.m. (standard blood glucose profiles with determinations at 6, 8, and 10 p.m, at midnight, at 2, 4, 6:45, 8:45 a.m., and at noon and 2, 6, and 8 p.m. of the following day). At 10 p.m. a late night snack (one slice of whole meal rye bread containing approximately 20 g of carbohydrate) was eaten or no nutrients were consumed, as determined by the randomization protocol. After one day without study-related activities, the study was repeated with the complementary protocol (crossover design). Patients were instructed to use fast-acting insulin to correct hyperglycemia three times per day (before major meals) or to take in additional carbohydrate when symptomatic or chemical hypoglycemia was noted. They were asked not to perform strenuous exercise beyond their normal daily activities.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Type 1 diabetes
  • Basal insulin substitution with insulin glargine at least 3 month
Exclusion Criteria
  • Severe disorders
  • Severe and clinical significant gastroparesis
  • History of pancreatitis or pancreatic cancer
  • Severe Liver disorder (liver enzymes > three times upper normal limit)
  • Pregnancy
  • Drug- or alcohol abuse

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Without late night snackNo late night snackNot nutrients (No late night snack) were consumed at 10 p.m. from Type 1 diabetic patients on an intensified conventional treatment regimen..
With late night snackLate night snackAt 10 p.m. a late night snack (one slice of whole meal rye bread containing approximately 20 g of carbohydrate) was eaten from Type 1 diabetic patients on an intensified conventional treatment regimen.
Primary Outcome Measures
NameTimeMethod
Hypoglycemia26 hours

Hypoglycemia with a plasma glucose ≤ 50 mg/dl as determined with a standardized laboratory method

Secondary Outcome Measures
NameTimeMethod
Blood glucose profile26 hours

The blood glucose profile with and without a late-night snack . (standard blood glucose profiles with determinations at 6, 8, and 10 p.m, at midnight, at 2, 4, 6:45, 8:45 a.m., and at noon and 2, 6, and 8 p.m. of the following day).

Trial Locations

Locations (1)

Diabeteszentrum Bad Lauterberg

🇩🇪

Bad Lauterberg, Niedersachsen, Germany

© Copyright 2025. All Rights Reserved by MedPath